Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression NR Wray, S Ripke, M Mattheisen, M Trzaskowski, EM Byrne, A Abdellaoui, ... Nature genetics 50 (5), 668-681, 2018 | 2541 | 2018 |
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease C Hock, U Konietzko, JR Streffer, J Tracy, A Signorell, B Müller-Tillmanns, ... Neuron 38 (4), 547-554, 2003 | 1094 | 2003 |
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 920 | 2017 |
Mismatch negativity in schizophrenia: a meta-analysis D Umbricht, S Krljes Schizophrenia research 76 (1), 1-23, 2005 | 865 | 2005 |
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt Archives of general psychiatry 57 (12), 1139-1147, 2000 | 698 | 2000 |
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia DC Javitt, SR Zukin, U Heresco-Levy, D Umbricht Schizophrenia bulletin 38 (5), 958-966, 2012 | 344 | 2012 |
How specific are deficits in mismatch negativity generation to schizophrenia? D Umbricht, R Koller, L Schmid, A Skrabo, C Grübel, T Huber, H Stassen Biological psychiatry 53 (12), 1120-1131, 2003 | 328 | 2003 |
Cognitive functioning in the schizophrenia prodrome AE Simon, K Cattapan-Ludewig, S Zmilacher, D Arbach, K Gruber, ... Schizophrenia bulletin 33 (3), 761-771, 2007 | 311 | 2007 |
Clozapine and weight gain. DS Umbricht, S Pollack, JM Kane The Journal of clinical psychiatry 55, 157-160, 1994 | 305 | 1994 |
Effects of clozapine on auditory event-related potentials in schizophrenia D Umbricht, D Javitt, G Novak, J Bates, S Pollack, J Lieberman, J Kane Biological psychiatry 44 (8), 716-725, 1998 | 287 | 1998 |
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers D Umbricht, R Koller, FX Vollenweider, L Schmid Biological psychiatry 51 (5), 400-406, 2002 | 285 | 2002 |
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison JM Kane, SR Marder, NR Schooler, WC Wirshing, D Umbricht, RW Baker, ... Archives of General Psychiatry 58 (10), 965-972, 2001 | 237 | 2001 |
Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study D Umbricht, D Alberati, M Martin-Facklam, E Borroni, EA Youssef, ... JAMA psychiatry 71 (6), 637-646, 2014 | 232 | 2014 |
The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics CH Miller, F Mohr, D Umbricht, M Woerner, WW Fleischhacker, ... Journal of Clinical Psychiatry 59 (2), 69-75, 1998 | 225 | 1998 |
Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia DSG Umbricht, JA Bates, JA Lieberman, JM Kane, DC Javitt Biological psychiatry 59 (8), 762-772, 2006 | 224 | 2006 |
Ultra high-risk state for psychosis and non-transition: a systematic review AE Simon, E Velthorst, DH Nieman, D Linszen, D Umbricht, L de Haan Schizophrenia research 132 (1), 8-17, 2011 | 200 | 2011 |
Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in … D Umbricht, FX Vollenweider, L Schmid, C Grübel, A Skrabo, T Huber, ... Neuropsychopharmacology 28 (1), 170-181, 2003 | 195 | 2003 |
Translating glutamate: from pathophysiology to treatment DC Javitt, D Schoepp, PW Kalivas, ND Volkow, C Zarate, K Merchant, ... Science translational medicine 3 (102), 102mr2-102mr2, 2011 | 193 | 2011 |
Postictal and chronic psychoses in patients with temporal lobe epilepsy D Umbricht, G Degreef, WB Barr, JA Lieberman, S Pollack, N Schaul American Journal of Psychiatry 152 (2), 224-231, 1995 | 190 | 1995 |
Trial of prasinezumab in early-stage Parkinson’s disease G Pagano, KI Taylor, J Anzures-Cabrera, M Marchesi, T Simuni, K Marek, ... New England Journal of Medicine 387 (5), 421-432, 2022 | 178 | 2022 |